INS and COVID-19: Kamyshnyi found that patients with diabetes had an aggravated course of disease after COVID-19, while after taking metformin, the insulin sensitivity and blood glucose levels decreased, which further reduced the risk of Corona Virus Disease 2019 (COVID-19) [109].